Lymphoma in Australia
The following material has been sourced from the Australian Institute of Health and Welfare
Lymphoma incorporates ICD-10 cancer codes C81 (Hodgkin’s disease), C82 (follicular non-Hodgkin’s lymphoma), C83 (diffuse non-Hodgkin’s lymphoma), C84 (peripheral and cutaneous T-cell lymphomas) and C85–C86 (other and unspecified types of non-Hodgkin’s lymphoma).
Estimated* number of new cases of lymphoma diagnosed in 2016
5,829 = 3,278 males + 2,551 females
Estimated % of all new cancer cases diagnosed in 2016
Estimated number of deaths from lymphoma in 2016
1,473 = 854 males + 619 females
Estimated % of all deaths from cancer in 2016
Chance of surviving at least 5 years (2008–2012)
People living with lymphoma at the end of 2010 (diagnosed in the 5 year period 2006 to 2010)
How common is lymphoma in Australia?
In 2012, there were 5,452 new cases of lymphoma diagnosed in Australia (3,093 males and 2,359 females).a In 2016, it is estimated that 5,829 new cases of lymphoma will be diagnosed in Australia (3,278 males and 2,551 females).b
In 2012, the age-standardised incidence rate was 22 cases per 100,000 persons (26 for males and 18 for females).d In 2016, it is estimated that the age-standardised incidence rate will be 21 cases per 100,000 persons (25 for males and 18 for females).
Lymphoma was the 6th most commonly diagnosed cancer in Australia in 2012. It is estimated that it will remain the 6th most commonly diagnosed cancer in 2016.
In 2016, it is estimated that the risk of an individual being diagnosed with lymphoma by their 85th birthday will be 1 in 38 (1 in 32 males and 1 in 45 females).
In 2016, it is expected the incidence rate of lymphoma will generally increase with age (see figure below).
Figure 1: Estimated age-specific incidence rates for lymphoma, 2016
Source: AIHW analysis of the Australian Cancer Database, (see source table 1).
Deaths from lymphoma
In 2013, there were 1,544 deaths from lymphoma in Australia (879 males and 665 females). In 2016, it is estimated that this will increase to 1,473 deaths (854 males and 619 females).c
In 2013, the age-standardised mortality rate was 5.8 deaths per 100,000 persons (7.3 for males and 4.5 for females).d In 2016, it is estimated that the age-standardised mortality rate will be 5.1 deaths per 100,000 persons (6.5 for males and 3.8 for females).
In 2013, lymphoma accounted for the 11th highest number of deaths from cancer in Australia. It is estimated that it will become the 12th most common cause of death from cancer in 2016.
In 2016, it is estimated that the risk of an individual dying from lymphoma by their 85th birthday will be 1 in 142 (1 in 111 for males and 1 in 189 for females).
Trends in lymphoma
The number of new cases of lymphoma diagnosed increased from 1,917 in 1982 to 5,452 in 2012.
Over the same period, the age-standardised incidence rate increased from 15 cases per 100,000 persons in 1982 to 22 cases per 100,000 persons in 2012.
The number of deaths from lymphoma increased from 662 in 1968 to 1,531 in 2013.
Over the same period, the age-standardised mortality rate increased from 7.0 deaths per 100,000 persons in 1968 to 9.3 deaths per 100,000 persons in 1997 before decreasing to 5.8 deaths per 100,000 in 2013.
Figure 2: Age-standardised incidence rates for lymphoma 1982–2012 and age-standardised mortality rates for lymphoma 1968–2013
Note: Incidence rates available for 1982–2012, and mortality rates available for 1968–2013.
Source: Australian Institute of Health and Welfare, (see source table 2).
Survival from lymphoma
In 2008–2012 in Australia, individuals diagnosed with lymphoma had a 75% chance of surviving for 5 years compared to their counterparts in the general Australian population.
Between 1983–1987 and 2008–2012, 5-year relative survival from lymphoma improved from 51% to 75%.
Figure 3: 5-year relative survival from lymphoma, 1983–1987 to 2008–2012
Source: AIHW analysis of the Australian Cancer Database, (see source table 3).
Prevalence of lymphoma
The prevalence for 1, 5 and 29 years given below are the number of people living with lymphoma at the end of 2010 who had been diagnosed in the preceding 1, 5 and 29 years respectively.
One year prevalence
At the end of 2010, there were 4,649 people living who had been diagnosed with lymphoma that year.
Five year prevalence
At the end of 2010, there were 18,367 people living who had been diagnosed with lymphoma in the previous 5 years (from 2006 to 2010).
29 year prevalence
At the end of 2010, there were 45,161 people living who had been diagnosed with lymphoma in the previous 29 years (from 1982 to 2010).
|Age group (years)||Number of new cases
per 100,000 persons
|Year||Rate of new diagnoses per 100,000 persons||Rate of deaths per 100,000 persons|
|Year||5-year relative survival (%)|
International Statistical Classification of Diseases and Related Health Problems Version 10 (ICD-10)
Cancer, like other health conditions, is classified by the International Statistical Classification of Diseases and Related Health Problems Version 10 (ICD-10). This is a statistical classification, published by the World Health Organization, in which each morbid condition is assigned a unique code according to established criteria.
Future estimates for incidence and mortality are a mathematical extrapolation of past trends. They assume that the most recent trends will continue into the future, and are intended to illustrate future changes that might reasonably be expected to occur if the stated assumptions continue to apply over the estimated period. Actual future cancer incidence and mortality rates may vary from these estimations for a variety of factors. New screening programs may increase the detection of new cancer cases; new vaccination programs may decrease the risk of developing cancer; and improvements in treatment options may decrease mortality rates.
Due to the rounding of these estimates, male and female incidence and mortality may not sum to person incidence and mortality.
Cancer incidence indicates the number of new cancers diagnosed during a specified time period (usually one year).
- The 2012 national incidence counts include estimates for NSW and the ACT because the actual data were not available.
- The 2016 estimates are based on 2002–11 incidence data. Due to rounding of these estimates, male and female incidence may not sum to person incidence.
Cancer mortality refers to the number of deaths occurring during a specified time period (usually one year) for which the underlying cause of death is cancer.
- The 2016 estimates are based on 2002–13 mortality data.
Prevalence of cancer refers to the number of people alive with a prior diagnosis of cancer at a given time. It is distinct from incidence (see above). The longest period for which it is possible to calculate prevalence using the available national data (from 1982 to 2010) is currently 29 years. This span is used to estimate the 'total' prevalence of cancer at the end of 2010, noting that people diagnosed with cancer before 1982 are not included.
Age standardised rates
- Incidence and mortality rates expressed per 100,000 population are age-standardised to the Australian population as at 30 June 2001.